These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30487734)

  • 1. Structural Basis of Tau Interaction With BIN1 and Regulation by Tau Phosphorylation.
    Lasorsa A; Malki I; Cantrelle FX; Merzougui H; Boll E; Lambert JC; Landrieu I
    Front Mol Neurosci; 2018; 11():421. PubMed ID: 30487734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformation and Affinity Modulations by Multiple Phosphorylation Occurring in the BIN1 SH3 Domain Binding Site of the Tau Protein Proline-Rich Region.
    Lasorsa A; Bera K; Malki I; Dupré E; Cantrelle FX; Merzougui H; Sinnaeve D; Hanoulle X; Hritz J; Landrieu I
    Biochemistry; 2023 Jun; 62(11):1631-1642. PubMed ID: 37167199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins - role of the SH3 domain.
    Malki I; Cantrelle FX; Sottejeau Y; Lippens G; Lambert JC; Landrieu I
    FEBS J; 2017 Oct; 284(19):3218-3229. PubMed ID: 28755476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau phosphorylation regulates the interaction between BIN1's SH3 domain and Tau's proline-rich domain.
    Sottejeau Y; Bretteville A; Cantrelle FX; Malmanche N; Demiaute F; Mendes T; Delay C; Alves Dos Alves H; Flaig A; Davies P; Dourlen P; Dermaut B; Laporte J; Amouyel P; Lippens G; Chapuis J; Landrieu I; Lambert JC
    Acta Neuropathol Commun; 2015 Sep; 3():58. PubMed ID: 26395440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging Integrator-1 protein loss in Alzheimer's disease promotes synaptic tau accumulation and disrupts tau release.
    Glennon EB; Lau DH; Gabriele RMC; Taylor MF; Troakes C; Opie-Martin S; Elliott C; Killick R; Hanger DP; Perez-Nievas BG; Noble W
    Brain Commun; 2020; 2(1):. PubMed ID: 32500121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr
    Sartori M; Mendes T; Desai S; Lasorsa A; Herledan A; Malmanche N; Mäkinen P; Marttinen M; Malki I; Chapuis J; Flaig A; Vreulx AC; Ciancia M; Amouyel P; Leroux F; Déprez B; Cantrelle FX; Maréchal D; Pradier L; Hiltunen M; Landrieu I; Kilinc D; Herault Y; Laporte J; Lambert JC
    Acta Neuropathol; 2019 Oct; 138(4):631-652. PubMed ID: 31065832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants.
    Pineda-Lucena A; Ho CS; Mao DY; Sheng Y; Laister RC; Muhandiram R; Lu Y; Seet BT; Katz S; Szyperski T; Penn LZ; Arrowsmith CH
    J Mol Biol; 2005 Aug; 351(1):182-94. PubMed ID: 15992821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic profiling of SH3-mediated Tau-Partner interaction network in Alzheimer's disease by integrating in silico analysis and in vitro assay.
    Wang X; Chang C; Wang D; Hong S
    J Mol Graph Model; 2019 Jul; 90():265-272. PubMed ID: 31112821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
    Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
    Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BIN1 membrane curvature sensing and generation show autoinhibition regulated by downstream ligands and PI(4,5)P2.
    Wu T; Baumgart T
    Biochemistry; 2014 Nov; 53(46):7297-309. PubMed ID: 25350771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the systematic effect of N-substituted PxxP motifs on peptoid affinity to ARHGEF5/TIM SH3 domain and its relationship with ARHGEF5/TIM activation.
    Fu Y; He P; Zhou Y; Huang S; Liang L; Liu S
    Proteins; 2019 Nov; 87(11):979-991. PubMed ID: 31197859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Phosphorylation and O-GlcNAcylation on Proline-Rich Domains of Tau.
    Rani L; Mittal J; Mallajosyula SS
    J Phys Chem B; 2020 Mar; 124(10):1909-1918. PubMed ID: 32065850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau-S214 Phosphorylation Inhibits Fyn Kinase Interaction and Increases the Decay Time of NMDAR-mediated Current.
    Jos S; Poulose R; Kambaru A; Gogoi H; Dalavaikodihalli Nanjaiah N; Padmanabhan B; Mehta B; Padavattan S
    J Mol Biol; 2024 Feb; 436(4):168445. PubMed ID: 38218365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bin1 antibody lowers the expression of phosphorylated Tau in Alzheimer's disease.
    Thomas S; Hoxha K; Tran A; Prendergast GC
    J Cell Biochem; 2019 Oct; 120(10):18320-18331. PubMed ID: 31211444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncovering the BIN1-SH3 interactome underpinning centronuclear myopathy.
    Zambo B; Edelweiss E; Morlet B; Negroni L; Pajkos M; Dosztanyi Z; Ostergaard S; Trave G; Laporte J; Gogl G
    Elife; 2024 Jul; 13():. PubMed ID: 38995680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SH3 domain of a M7 interacts with its C-terminal proline-rich region.
    Wang Q; Deloia MA; Kang Y; Litchke C; Zhang N; Titus MA; Walters KJ
    Protein Sci; 2007 Feb; 16(2):189-96. PubMed ID: 17189480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SH3 domain recognition of a proline-independent tyrosine-based RKxxYxxY motif in immune cell adaptor SKAP55.
    Kang H; Freund C; Duke-Cohan JS; Musacchio A; Wagner G; Rudd CE
    EMBO J; 2000 Jun; 19(12):2889-99. PubMed ID: 10856234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus NS5A is able to competitively displace c-Myc from the Bin1 SH3 domain in vitro.
    Aladag A; Hoffmann S; Stoldt M; Bösing C; Willbold D; Schwarten M
    J Pept Sci; 2014 May; 20(5):334-40. PubMed ID: 24616074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the SH3 domain of human osteoclast-stimulating factor with rationally designed peptoid inhibitors.
    Han S; Liu Q; Wang F; Yuan Z
    J Pept Sci; 2016 Aug; 22(8):533-9. PubMed ID: 27443979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SH3 domain of Caskin1 binds to lysophosphatidic acid suggesting a direct role for the lipid in intracellular signaling.
    Koprivanacz K; Tőke O; Besztercei B; Juhász T; Radnai L; Merő B; Mihály J; Péter M; Balogh G; Vígh L; Buday L; Liliom K
    Cell Signal; 2017 Apr; 32():66-75. PubMed ID: 28104445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.